Filing Details

Accession Number:
0001209191-22-002753
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-01-10 18:37:47
Reporting Period:
2022-01-06
Accepted Time:
2022-01-10 18:37:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1544227 Tempest Therapeutics Inc. TPST Pharmaceutical Preparations (2834) 451472564
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1870373 Samuel Whiting Tempest Therapeutics, Inc.
7000 Shoreline Court, Suite 275
South San Francisco CA 94080
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-01-06 1,700 $4.80 1,901 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct